Table 3.
Parameter | Univariable analysis |
Multivariable analysis |
||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Age | 1.013 | 0.977–1.049 | .495 | 0.984 | 0.930–1.042 | .584 |
FIGO | 2.330 | 1.456–3.728 | < .001 | 0.960 | 0.473–1.948 | .910 |
Grade | 1.512 | 0.928–2.463 | .097 | 0.886 | 0.409–1.846 | .714 |
Lymphovascular invasion | 1.083 | 1.043–1.124 | < .001 | 0.986 | 0.940–1.032 | .544 |
Myometrial invasion | 1.014 | 1.012–1.052 | < .001 | 0.978 | 0.937–1.048 | .587 |
MELF pattern | 4.510 | 1.938–6.342 | < .001 | 3.472 | 3.109–3.877 | < .001 |
No. of vessels | 1.026 | 1.014–1.038 | < .001 | 1.007 | 0.989–1.025 | .441 |
Area of vessels | 1.002 | 1.001–1.004 | < .001 | 1.000 | 0.999–1.000 | .431 |
VEGF | 1.049 | 1.029–1.068 | < .001 | 1.004 | 0.968–1.043 | .813 |
Galectin-1 | 1.037 | 1.023–1.057 | < .001 | 1.050 | 1.016–1.084 | .003 |
CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; MELF, microcystic, elongated and fragmented; VEGF, vascular endothelial growth factor.